Evidence map›Paper›PMID 16027371›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Variant tricarboxylic acid cycle in Mycobacterium tuberculosis: identification of alpha-ketoglutarate decarboxylase.

Jing Tian, Ruslana Bryk, Manabu Itoh, Makoto Suematsu, Carl Nathan

Abstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 196 citations in OpenAlex.

  1. Trial
  2. Article
  3. A cloaked glutamate decarboxylase sustains the GABA shunt inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Evaluation of the role ofMicrobiology spectrum · 2025
    Article
  8. Article
  9. Review
  10. Insights into Active Site Cysteine Residues inInternational journal of molecular sciences · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. TheMicroorganisms · 2023
    Article
  16. Article
  17. Article
  18. EngineeringBiotechnology reports (Amsterdam, Netherlands) · 2022
    Article
  19. Pan-genome association study ofFrontiers in microbiology · 2022
    Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jing TianDepartment of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA.
Ruslana Bryk
Manabu Itoh
Makoto Suematsu
Carl Nathan
Cornell University · USKeio University · JP

Funding

TARGETING DEFENSES OF MYCOBACTERIUM TUBERCULOSISR01HL072718 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI NATHAN, CARL F · 2002 to 2004
$1.6M
NHLBI NIH HHS HL72718NHLBI NIH HHS R01 HL072718
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) has adapted its metabolism for persistence in the human macrophage. The adaptations are likely to involve Mtb's core intermediary metabolism, whose enzymes have been little studied. The tricarboxylic acid cycle is expected to yield precursors for energy, lipids, amino acids, and heme. The genome sequence of Mtb H37Rv predicts the presence of a complete tricarboxylic acid cycle, but we recently found that alpha-ketoglutarate dehydrogenase (KDH) activity is lacking in Mtb lysates. Here we showed that citrate synthase, aconitase, isocitrate dehydrogenase, fumarase, malate dehydrogenase, and succinate dehydrogenase, but not KDH, are present, raising the possibility of separate oxidative and reductive half-cycles. As a potential link between the half-cycles, we found that Rv1248c, annotated as encoding SucA, the putative E1 component of KDH, instead encodes alpha-ketoglutarate decarboxylase (Kgd) and produces succinic semialdehyde. Succinic semialdehyde dehydrogenase activity was detected in Mtb lysates and recapitulated with recombinant proteins GabD1 (encoded by Rv0234c) and GabD2 (encoded by Rv1731). Kgd and GabD1 or GabD2 form an alternative pathway from alpha-ketoglutarate to succinate. Rv1248c, which is essential or required for normal growth of Mtb [Sassetti, C., Boyd, D. H. & Rubin, E. J. (2003) Mol. Microbiol 48, 77-84] is the first gene shown to encode a Kgd. Kgd is lacking in humans and may represent a potential target for chemotherapy of tuberculosis.

Indexed as

Bacterial ProteinsBlotting, WesternCarboxy-LyasesCitric Acid CycleEnzymesgamma-Aminobutyric AcidGlutamic AcidMycobacterium tuberculosisNuclear Magnetic Resonance, BiomolecularSpecies Specificity2-oxoglutarate decarboxylaseBacterial ProteinsCarboxy-LyasesEnzymesgamma-Aminobutyric AcidGlutamic Acidsuccinic semialdehyde

Identifiers

PMID16027371
PMCPMC1180764
OpenAlexW2055531830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.